-
Senti Bio Determines Recommended Phase 2 Dose (RP2D) in Phase 1 Study of SENTI-202 for the Treatment of Relapsed/Refractory Hematologic Malignancies, Including Acute Myeloid Leukemia
05 Aug 2025 12:30 GMT
… These Gene Circuits are designed to precisely kill cancer cells … preclinical or previous clinical study data; expectations regarding … clinical trial startup, clinical studies, and GMP manufacturing activities … of any future research and development efforts by …
-
Elicio Therapeutics Announces Positive Recommendation by IDMC to Continue ELI-002 7P Randomized Phase 2 Study in Pancreatic Cancer Without Modifications to Final Analysis
05 Aug 2025 11:00 GMT
… -positive colorectal cancer (“CRC”) in Phase 1 studies. The updated … survival for the full study population. In the future … relapse risk mKRAS-driven solid tumors, following surgery and chemotherapy … ; Elicio’s plans to research, develop and commercialize its …
-
Immutep Receives Positive Feedback from FDA on Late-Stage Clinical Development of Eftilagimod Alfa in Head and Neck Cancer with CPS <1
05 Aug 2025 12:00 GMT
… -stage immunotherapy company targeting cancer and autoimmune diseases, today … by a confirmatory randomised study that builds on the … developing novel immunotherapies for cancer and autoimmune disease. The … related to Lymphocyte Activation Gene-3 (LAG-3), …
-
Danish Aluminium Vaccine Study: Professor Fact Checks RFK Jr
05 Aug 2025 03:02 GMT
… of children based on known genetic risk factors, such as … of safety is scientifically indefensible.
Three of the study’s authors … on non-reproducible observational studies that are not merely … of harm, but independent research grounded in full transparency, …
-
UCLA study shows stem cells can be reprogrammed to fight cancer
05 Aug 2025 02:26 GMT
… study, published in Nature Communications and led by physician-scientist … to-treat cancers, especially solid tumors that … gene modified stem cells, which then produce the genetically-redirected cancer … Wheels, the Tower Cancer Research Foundation, the Parker …
-
Immune Landscape in Colorectal Cancer KRAS Variants
05 Aug 2025 02:25 GMT
… a groundbreaking study published in BMC Cancer, researchers have unveiled … immune cells within tumors, offering promising new … tumor-immune interactions in genetically heterogeneous cancers.
As immunotherapy continues to revolutionize oncology, studies …
-
Emerging Study Explores Rising Colorectal Cancer Rates and Screening Trends in Younger US Adults
05 Aug 2025 02:25 GMT
… recent series of studies published in … age-specific cancer pathogenic mechanisms, including genetic and … advance our scientific understanding of colorectal cancer epidemiology … demographic.
Subject of Research: Colorectal cancer incidence and screening …
-
Revitalizing Exhausted CD8+ T Cells to Combat Cancer and Chronic Viral Infections
05 Aug 2025 02:25 GMT
… patterns, indicating differential gene regulatory networks compared … effectively, with minimal tumor growth inhibition and … patients with immunotherapy-resistant tumors.
Lewis Z. Shi … study significantly advances the frontiers of immunology and cancer research …
-
Leeds To Strengthen Position As UK’s Largest Research Centre Outside Golden Triangle
05 Aug 2025 01:51 GMT
… analogue to digital; health inequalities research targeting socioeconomic health gaps; … developing gene therapies, immunotherapies and preventative vaccines; and patient outcomes research … global research, with 96 per cent of 40,000 patients with cancer …
-
Doubling chemotherapy effectiveness in resistant cancer treatment
05 Aug 2025 00:16 GMT
… rarely disappears. While genetic mutations contribute to this … to lead researcher Vadim Backman: “Cancer cells are great … macromolecules including DNA, RNA and proteins — determines which genes are … vivo experiments, the scientists discovered that the three …